Surgery
Vascular Surgery
Vascular surgeons diagnose, treat, and manage conditions of your arteries and veins, also called your blood vessels. These specialists treat a range of health problems, from spider and varicose veins to life-threatening aneurysms, and can help patients manage chronic conditions throughout their lives.
Peripheral artery disease (also called peripheral arterial disease) is a common circulatory problem in which narrowed arteries reduce blood flow to your limbs. When you develop peripheral artery disease (PAD), your extremities — usually your legs — don't receive enough blood flow to keep up with demand. This causes symptoms, most notably leg pain when walking (claudication). Peripheral artery disease is also likely to be a sign of a more widespread accumulation of fatty deposits in your arteries (atherosclerosis). This condition may be reducing blood flow to your heart and brain, as well as your legs.
At USF Health, our board certified vascular surgeons have expertise in the management of a wide-range of vascular diseases utilizing the most advanced medical therapy, surgical or endovascular procedure at Tampa General Hospital, a Level I Trauma Center, as well as James Haley Veterans’ Hospital and Bay Pines VA Hospital.
USF Health is also home to the Comprehensive Vein Center, a center dedicated to treating the full spectrum of venous disease.
Vascular Services
- Aortic aneurysm
- Aortic care
- Arteriovenous access for hemodialysis
- Carotid artery disease, blockage and aneurysms
- Deep vein thrombosis and thrombophlebitis
- Entrapment syndromes
- Leg pain and foot wounds
- Leg swelling
- Lower extremity blockage
- Peripheral arterial disease
- Renal and mesenteric arterial oclusive disease
- Thoracic and abdominal aneurysms
- Thoracic outlet syndrome
- Varicose veins and blood clots
- Vascular trauma
- Vein disease
Clinical Trials
-
Summary: The purpose of this registry is to collect mid-term and long-term post-market clinical follow-up data for the EXCC or IBE devices used in standard medical practice.
Trial Information: https://clinicaltrials.gov/study/NCT06218875?term=TGR%2023-02AA&rank=1
Contact information: Eric Johnson, 610-573-4814, eej11@usf.edu
Additional Information: Currently recruiting -
Summary: The purpose of this registry is to collect mid-term and long-term post-market clinical follow-up data for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System used in standard medical practice.
Trial Information: https://clinicaltrials.gov/study/NCT06658730?term=TGR%2023-02TA&rank=1
Contact information: Eric Johnson, 610-573-4814, eej11@usf.edu
Additional Information: Currently recruiting -
Summary: This study assesses the safety and effectiveness of the ASG device in the treatment of lesions involving the ascending aorta and aortic arch.
Trial Information: https://clinicaltrials.gov/study/NCT05800743?term=GORE%C2%AE%20Ascending%20Stent%20Graft&rank=2#locations
Contact information: Eric Johnson, 610-573-4814, eej11@usf.edu
Additional Information: Currently recruiting -
Summary: Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ischemia. However, supervised exercise is inaccessible or burdensome for most PAD patients. Investigators hypothesize that home-based exercise combined with lower extremity revascularization will significantly improve walking performance compared to revascularization alone in patients with PAD undergoing revascularization for disabling PAD.
Trial Information: https://clinicaltrials.gov/study/NCT06686121?term=IMPACT%20PAD&rank=2
Contact information: Jose Reyes, 813-753-7793, josereyes@usf.edu
Additional Information: Currently recruiting -
Summary: The purpose of this study is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.
Trial Information: https://clinicaltrials.gov/expert-search?term=FORWARD%20GORE%C2%AE%20VIABAHN%C2%AE%20VBX%20Balloon
Contact information: Jose Reyes, 813-753-7793, josereyes@usf.edu
Additional Information: Currently recruiting -
Summary: The purpose of this study is to examine the efficacy and safety of colchicine 0.5 mg/daily in reducing the incidence of cardiovascular death, myocardial infarction, stroke or severe limb ischemia requiring an intervention including major vascular amputation in PAD patients.
Trial Information: https://clinicaltrials.gov/study/NCT04774159?term=LEADER-PAD&rank=1
Contact information: Jose Reyes, 813-753-7793, josereyes@usf.edu
Additional Information: Currently recruiting -
Summary: The main goal of this clinical trial is to determine the effectiveness and safety of the sirolimus drug coated balloon (DCB) versus standard percutaneous transluminal angioplasty (PTA) for the treatment of below the knee arterial disease.
Trial Information: https://clinicaltrials.gov/study/NCT06182397?term=Magical%20BTK&rank=1
Contact information: Jose Reyes, 813-753-7793, josereyes@usf.edu
Additional Information: Currently recruiting -
Summary: The primary objective of this study is to collect and evaluate clinical evidence supporting the safety and performance of the Indigo™ Aspiration System in a patient population with lower extremity acute limb ischemia.
Trial Information: https://clinicaltrials.gov/study/NCT06747117?term=STRIDE%20II&rank=8
Contact information: Jose Reyes, 813-753-7793, josereyes@usf.edu
Additional Information: Currently recruiting -
Summary: The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries.
Trial Information: https://clinicaltrials.gov/study/NCT04875429?term=Zenith%C2%AE%20Fenestrated%2B%20Endovascular%20Graft&rank=2
Contact information: Eric Johnson, 610-573-4814, eej11@usf.edu
Additional Information: Currently recruiting -
Summary: The goal of the CSP-2002 clinical trial is to evaluate the safety and effectiveness of the InnAVasc Arteriovenous Graft (IG) for hemodialysis (HD) access in patients with end-stage renal disease (ESRD).
Trial Information: https://clinicaltrials.gov/study/NCT04671771?term=Innavasc&rank=2#locations
Contact information: Jose Reyes, 813-753-7793, josereyes@usf.edu
Additional Information: Currently recruiting
USF Health and Tampa General Hospital Working Together
USF Health vascular surgeons work closely with Tampa General Hospital’s Heart and Vascular Institute Aortic Disease to offer advanced care to patients with aortic conditions.
Patients can directly contact the Aortic Disease Program and physicians can refer a patient by calling: (813) 844-3900, Monday through Friday, 8:00 a.m. to 4:30 p.m.
For patients with aneurysms - please contact the TGH Aortic Disease Program – a coordinator will contact patients within 24 hours.
Meet Our Experts
-
Jeni Brewster, PA
Jeni Brewster, PA
